gastric cancer Clinical Trials and Research
Also known as: stomach cancer, gastric adenocarcinoma, cancer of the stomach, gastric carcinoma, stomach neoplasm · ICD-10: C16
Gastric cancer, also known as stomach cancer, begins in the cells lining the stomach. Clinical trial research focuses on developing new therapies, improving early detection methods, and understanding disease progression. Find a Trial helps patients and caregivers search for active studies.
Search gastric cancer trials →
Common questions about gastric cancer clinical trials
Who can participate in gastric cancer clinical trials?
Eligibility criteria vary by study but often include specific cancer stage, overall health, and prior treatments. Researchers ensure participant safety and study relevance. Patients should discuss their medical history with the study team. Data from ClinicalTrials.gov.
What are the different phases of clinical trials for gastric cancer?
Trials typically progress through phases 1-3. Phase 1 assesses safety, phase 2 evaluates effectiveness, and phase 3 compares new treatments to standard care. Each phase has distinct goals for advancing medical knowledge. Data from ClinicalTrials.gov.
Do clinical trials for gastric cancer cost money?
Study-related medical costs are often covered by the trial sponsor. However, routine medical care costs may still be the participant's responsibility. Patients should confirm financial details with the study team before enrolling. Data from ClinicalTrials.gov.
What types of treatments are being studied in gastric cancer trials?
Researchers are investigating targeted therapies, immunotherapies, chemotherapy combinations, and novel surgical or radiation techniques. The goal is to improve outcomes and reduce side effects for patients. Data from ClinicalTrials.gov and NIH RePORTER.
What are common research directions for gastric cancer?
Active research explores personalized medicine approaches, identifying new biomarkers for early detection, and preventing recurrence. Studies also aim to improve quality of life for patients. Data from ClinicalTrials.gov and NIH RePORTER.
Are there specific biomarkers important in gastric cancer clinical trials?
Yes, biomarkers like HER2 status, PD-L1 expression, and microsatellite instability (MSI) are often assessed. These help identify patients who might respond best to certain targeted or immunotherapies. Data from ClinicalTrials.gov and NIH RePORTER.
What are common exclusion criteria in gastric cancer trials?
Common exclusions might include significant co-existing medical conditions, certain prior treatments, or specific laboratory abnormalities. These criteria help ensure patient safety and study integrity. Data from ClinicalTrials.gov.
How do clinical trials for gastric cancer aim to improve patient outcomes?
Trials seek to develop more effective treatments, improve diagnostic accuracy, and minimize treatment side effects. They also explore ways to enhance patient quality of life and extend survival. Data from ClinicalTrials.gov and NIH RePORTER.
How to find a gastric cancer trial that fits you
- Describe your gastric cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all gastric cancer trials →